James Nugent
Overview
Explore the profile of James Nugent including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dorling M, Sarafan M, Voizard B, Ammar Y, Hernaiz-Leonardo J, Chalmers K, et al.
Int Forum Allergy Rhinol
. 2024 Oct;
15(2):166-173.
PMID: 39422074
Background: Type 2 biologics have been used increasingly for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). However, patterns of biologic switching are understudied, and established guidelines for sequential...
2.
Aklilu A, Kumar S, Nugent J, Yamamoto Y, Coronel-Moreno C, Kadhim B, et al.
JAMA Intern Med
. 2024 Feb;
184(4):414-423.
PMID: 38407862
Importance: COVID-19 infection is associated with a high incidence of acute kidney injury (AKI). Although rapid kidney function decline has been reported in the first few months after COVID-19-associated AKI...
3.
Nugent J, Aklilu A, Yamamoto Y, Simonov M, Li F, Biswas A, et al.
JAMA Netw Open
. 2021 Mar;
4(3):e211095.
PMID: 33688965
Importance: Acute kidney injury (AKI) occurs in up to half of patients hospitalized with coronavirus disease 2019 (COVID-19). The longitudinal effects of COVID-19-associated AKI on kidney function remain unknown. Objective:...
4.
Nugent J, Childers M, Singh-Miller N, Howard R, Allard R, Eberly M
J Pediatr
. 2019 Jun;
212:102-110.e5.
PMID: 31230888
Objective: To determine the risk of bacterial meningitis in infants aged 29-90 days with evidence of urinary tract infection (UTI). Methods: PubMed (MEDLINE), Embase, and the Cochrane Library were systematically...
5.
Nugent J, Gorman G, Erdie-Lalena C
J Pediatr
. 2018 Mar;
197:214-220.
PMID: 29571933
Objective: To compare healthcare transition planning in adolescents with Down syndrome with adolescents with other special healthcare needs. Study Design: Data were drawn from the 2009-2010 National Survey of Children...
6.
So W, Kuti J, Shepard A, Nugent J, Nicolau D
Int J Antimicrob Agents
. 2016 Feb;
47(3):247-8.
PMID: 26897754
No abstract available.
7.
Housman S, Bhalodi A, Shepard A, Nugent J, Nicolau D
J Am Podiatr Med Assoc
. 2015 Oct;
105(5):381-8.
PMID: 26429605
Background: Vancomycin is a common treatment option for skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Given the increasing prevalence of MRSA, vancomycin is widely used as...
8.
Nugent J, Edmonds A, Lusiama J, Thompson D, Behets F
Pediatr Infect Dis J
. 2014 Jun;
33(11):1148-55.
PMID: 24945879
Background: While highly active antiretroviral therapy (HAART) programs have been scaled up across sub-Saharan Africa, no prognostic models for the prediction of mortality risk for children initiating HAART are widely...
9.
Bhalodi A, Housman S, Shepard A, Nugent J, Nicolau D
Antimicrob Agents Chemother
. 2013 Sep;
57(11):5679-83.
PMID: 24041887
Cefazolin, a first-generation cephalosporin with activity against methicillin-susceptible Staphylococcus aureus and streptococci, is often used to treat lower limb infections caused by these pathogens. Antimicrobial penetration is often limited in...